metoprolol has been researched along with Body Weight in 50 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketanserin, an investigational, antiserotonergic agent, at a dose of 40 mg bid was given to 18 patients with mild to moderate primary hypertension in a randomized, double-blind, crossover study, with 100-mg metoprolol bid for four weeks each." | 9.05 | Cardiovascular effects of ketanserin, a new antiserotonergic agent in the treatment of arterial hypertension. ( Fasano, ML; Ferrara, LA; Iannuzzi, A; Rubba, P; Soro, S, 1985) |
| "Seventy-one patients with mild-to-moderate essential hypertension completed 14 weeks' treatment with a single daily dose of fixed combination of metoprolol tartrate 100 mg and chlorthalidone 25 mg (Logroton; Geigy)." | 9.05 | A fixed combination of metoprolol and chlorthalidone in hypertension. A clinical trial in general practice. ( Govind, U; Munro, BF; Robertson, LI, 1981) |
| "Weight reduction was compared with metoprolol (200 mg daily) in a randomised placebo-controlled trial of first-line treatment of mild hypertension (diastolic blood pressure 90-109 mm Hg) in 56 overweight patients aged under 55 years." | 9.05 | Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients. ( Andrews, G; Bernstein, L; Blacket, RB; Macdonald, GJ; MacMahon, SW, 1985) |
| "After a control period on a placebo, 45 patients with mild to moderate hypertension were treated with metoprolol, 100 mg twice daily alone and in free combination with chlorthalidone 50 mg daily using a double-blind crossover technique." | 9.04 | Metoprolol with and without chlorthalidone in hypertension. ( Ebbutt, A; John, V; Kendall, M; Kubik, M, 1979) |
| "The antihypertensive effects on metoprolol and pindolol were compared in 50 patients with essential hypertension belonging to WHO stage 1 or 2." | 9.04 | A comparison between metoprolol and pindolol in the treatment of essential hypertension. ( Pohjola, M; Tuomilehto, J, 1978) |
| "The effects of chlorthalidone and metoprolol on fasting plasma lipids and lipoprotein levels were compared in two similar nonrandomized groups of patients with mild hypertension." | 7.67 | Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status. ( Goldbourt, U; Holtzman, E; Rosenthal, T; Segal, P, 1984) |
| " Experimental hyperthyroidism was induced by daily intraperitoneal injections of triiodothyronine (T3; 100 micrograms/100 g body weight) for 3 days." | 7.67 | Effects of beta-blocking agents on urinary excretion of 3-methylhistidine during experimental hyperthyroidism in rats. ( Angerås, U; Hasselgren, PO; Jagenburg, R; Lindstedt, G, 1987) |
| "Sibutramine treatment resulted in a significantly greater decrease in body weight, body mass index, and waist circumference and a significant increase in diastolic blood pressure during 24-hour blood pressure monitoring compared with placebo treatment." | 6.73 | Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study. ( Grimm, E; Herrmann, D; Kintscher, U; Scholze, J; Unger, T, 2007) |
| " Altogether, 251 hypertensive patients with a diastolic blood pressure greater than 95 mm Hg after 4 weeks of treatment with placebo in combination with metoprolol CR 100 mg were randomized to four parallel groups." | 6.67 | Optimal felodipine dose when combined with metoprolol in arterial hypertension: a Swedish multicenter study within primary health care. Swedish General Practitioner Felodipine Study Group. ( Bengtsson, C; Brun, J; Fröberg, L; Kronmann, P; Olsson, LB; Scherstén, B; Skoog, P; Tibblin, G; Tygesen, G, 1990) |
| "Treatment with growth hormone alone or in combination with metoprolol preserved left ventricular function after MI." | 5.31 | Growth hormone alone or combined with metoprolol preserves cardiac function after myocardial infarction in rats. ( Bengtsson, BA; Bergh, CH; Bollano, E; Caidahl, K; Isgaard, J; Kjellström, C; Kujacic, V; Omerovic, E; Waagstein, F, 2001) |
| " The current analysis of the Glycemic Effect in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial evaluates the effects of carvedilol and metoprolol tartrate on weight gain in patients with type 2 diabetes and hypertension." | 5.12 | Body weight changes with beta-blocker use: results from GEMINI. ( Anderson, KM; Bakris, GL; Bangalore, S; Bell, DS; Fonseca, V; Holdbrook, FK; Katholi, RE; Lukas, MA; McGill, JB; Messerli, FH; Phillips, RA; Raskin, P; Wright, JT, 2007) |
| "After 4 days of drug treatment with comparable doses of propranolol (40 and 80 mg), metoprolol (50 and 100 mg), or placebo, mood (POMS) and anxiety states (STAI) were assessed in healthy volunteers, before and after 1 h of treadmill walking exercise at 50% maximum oxygen uptake." | 5.08 | Acute effects of beta blockade and exercise on mood and anxiety. ( Eagles, C; Ferner, R; Head, A; Kendall, MJ, 1996) |
| "Weight reduction was compared with metoprolol (200 mg daily) in a randomized placebo-controlled trial of first-line treatment of mild hypertension (diastolic blood pressure 90-109 mm Hg) in 56 overweight patients aged under 55 years." | 5.06 | Treatment of high blood pressure in overweight patients. ( Macdonald, G; MacMahon, S, 1987) |
| "We compared the effects of weight reduction, metoprolol, and placebo on M-mode echocardiographic measurements of the thickness and mass of the left ventricular wall in a 21-week, randomized controlled trial that enrolled 41 young, overweight patients with hypertension." | 5.06 | The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients. ( Macdonald, GJ; MacMahon, SW; Wilcken, DE, 1986) |
| "Weight reduction was compared with metoprolol (200 mg daily) in a randomised placebo-controlled trial of first-line treatment of mild hypertension (diastolic blood pressure 90-109 mm Hg) in 56 overweight patients aged under 55 years." | 5.05 | Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients. ( Andrews, G; Bernstein, L; Blacket, RB; Macdonald, GJ; MacMahon, SW, 1985) |
| "Ketanserin, an investigational, antiserotonergic agent, at a dose of 40 mg bid was given to 18 patients with mild to moderate primary hypertension in a randomized, double-blind, crossover study, with 100-mg metoprolol bid for four weeks each." | 5.05 | Cardiovascular effects of ketanserin, a new antiserotonergic agent in the treatment of arterial hypertension. ( Fasano, ML; Ferrara, LA; Iannuzzi, A; Rubba, P; Soro, S, 1985) |
| "Seventy-one patients with mild-to-moderate essential hypertension completed 14 weeks' treatment with a single daily dose of fixed combination of metoprolol tartrate 100 mg and chlorthalidone 25 mg (Logroton; Geigy)." | 5.05 | A fixed combination of metoprolol and chlorthalidone in hypertension. A clinical trial in general practice. ( Govind, U; Munro, BF; Robertson, LI, 1981) |
| "The antihypertensive effect of slow-release metoprolol was studied in 50 patients suffering from mild to moderate essential hypertension." | 5.05 | A double-blind crossover comparative study of the efficacy of single daily doses of conventional and slow-release metoprolol. ( Harvard, CW; Nievel, JG, 1981) |
| "A crossover comparison of metoprolol and hydrochlorothiazide has been performed in 20 patients with mild hypertension." | 5.04 | Comparison of metoprolol as hydrochlorothiazide and antihypertensive agents. ( Pedersen, OL, 1976) |
| "The antihypertensive effects on metoprolol and pindolol were compared in 50 patients with essential hypertension belonging to WHO stage 1 or 2." | 5.04 | A comparison between metoprolol and pindolol in the treatment of essential hypertension. ( Pohjola, M; Tuomilehto, J, 1978) |
| "After a control period on a placebo, 45 patients with mild to moderate hypertension were treated with metoprolol, 100 mg twice daily alone and in free combination with chlorthalidone 50 mg daily using a double-blind crossover technique." | 5.04 | Metoprolol with and without chlorthalidone in hypertension. ( Ebbutt, A; John, V; Kendall, M; Kubik, M, 1979) |
| "One day after induction of anti-thy1 glomerulonephritis, rats were given increasing doses of the beta-blockers metoprolol or nebivolol (0." | 3.72 | Angiotensin-converting enzyme inhibition but not beta-adrenergic blockade limits transforming growth factor-beta overexpression in acute normotensive anti-thy1 glomerulonephritis. ( Gaedeke, J; Ketteler, M; Liefeldt, L; Neumayer, HH; Peters, H; Rückert, M; Sharma, AM, 2003) |
| "Body weight and plasma norepinephrine, leptin, and insulin levels were measured in 27 subjects with CHF before and after 6 months of beta-adrenergic receptor blockade with carvedilol or long-acting metoprolol." | 3.72 | Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure. ( Androne, AS; Hryniewicz, K; Hudaihed, A; Katz, SD, 2003) |
| " Experimental hyperthyroidism was induced by daily intraperitoneal injections of triiodothyronine (T3; 100 micrograms/100 g body weight) for 3 days." | 3.67 | Effects of beta-blocking agents on urinary excretion of 3-methylhistidine during experimental hyperthyroidism in rats. ( Angerås, U; Hasselgren, PO; Jagenburg, R; Lindstedt, G, 1987) |
| "The effects of chlorthalidone and metoprolol on fasting plasma lipids and lipoprotein levels were compared in two similar nonrandomized groups of patients with mild hypertension." | 3.67 | Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status. ( Goldbourt, U; Holtzman, E; Rosenthal, T; Segal, P, 1984) |
| "Experimental hyperthyroidism was induced in rats by daily intraperitoneal injections of triiodothyronine (T3; 100 micrograms/100 g bw) for 3 days (short-term experiment) or by subcutaneous injections of T3 (30 micrograms/100 g bw) on alternate days during 6 weeks (long-term experiment)." | 3.67 | Effects of thyroid hormone and beta-blocking agents on plasma amino acids in rats. ( Angerås, U; Hasselgren, PO; Jagenburg, R, 1986) |
| "Sibutramine treatment resulted in a significantly greater decrease in body weight, body mass index, and waist circumference and a significant increase in diastolic blood pressure during 24-hour blood pressure monitoring compared with placebo treatment." | 2.73 | Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study. ( Grimm, E; Herrmann, D; Kintscher, U; Scholze, J; Unger, T, 2007) |
| "Metoprolol is a widely used beta1-selective beta-blocker in hypertension and tachycardia." | 2.71 | Relation between pharmacodynamic and anthropometric parameters during ergometry at rest and after repeated intake of metoprolol in healthy volunteers: results of a pilot study. ( Koch, HJ; Raschka, C, 2004) |
| " Altogether, 251 hypertensive patients with a diastolic blood pressure greater than 95 mm Hg after 4 weeks of treatment with placebo in combination with metoprolol CR 100 mg were randomized to four parallel groups." | 2.67 | Optimal felodipine dose when combined with metoprolol in arterial hypertension: a Swedish multicenter study within primary health care. Swedish General Practitioner Felodipine Study Group. ( Bengtsson, C; Brun, J; Fröberg, L; Kronmann, P; Olsson, LB; Scherstén, B; Skoog, P; Tibblin, G; Tygesen, G, 1990) |
| "When bendroflumethiazide was added the favourable effect of captopril on the blood lipids disappeared while the undesirable effect of metoprolol became more pronounced." | 2.67 | The effect of captopril and metoprolol as monotherapy or combined with bendroflumethiazide on blood lipids. ( Foss, OP; Jensen, EK, 1990) |
| " Overall, the withdrawal rate due to adverse events during the first 12 months of treatment was 6." | 2.67 | The long-term antihypertensive efficacy and safety of a new felodipine-metoprolol combination tablet. The Swedish/UK and German Study Groups. ( Dahlöf, B; Hosie, J; Klein, G, 1993) |
| " After 12 weeks of active treatment, reductions in supine systolic/diastolic blood pressure 24 h after dosing were 20/14, 13/10 and 11/8 mmHg with felodipine-metoprolol, felodipine and metoprolol, respectively." | 2.67 | Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group. ( Dahlöf, B; Hosie, J, 1993) |
| "Carvedilol (BM 14190) is a new potent and well-tolerated beta-adrenoceptor antagonist with vasodilating properties." | 2.66 | Circadian antihypertensive profile of carvedilol (BM 14190). ( Distler, A; Gotzen, R; Meyer-Sabellek, W; Schulte, KL, 1987) |
| "The prophylactic anti-migraine effect of the serotonin antagonist pizotifen and the beta 1-selective beta-adrenoceptor antagonist metoprolol was compared in a double-blind cross-over study." | 2.66 | Metoprolol and pizotifen in the prophylactic treatment of classical and common migraine. A double-blind investigation. ( Hedman, C; Standnes, B; Vilming, S, 1985) |
| "With metoprolol there was an increase in right ventricular end-diastolic and end-systolic volumes." | 1.39 | Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathy. ( Blain, A; Blamire, A; Greally, E; Laval, S; MacGowan, GA; Straub, V, 2013) |
| " In summary, the present study provides the first evidence of a change in the in vitro pharmacodynamic properties of metoprolol in SHR." | 1.34 | Changes in the in vitro pharmacodynamic properties of metoprolol in atria isolated from spontaneously hypertensive rats. ( Di Verniero, C; Höcht, C; Opezzo, JA; Taira, CA, 2007) |
| "Metoprolol and/or PQQ were given at the onset of reperfusion to mimic clinical treatment." | 1.33 | Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury. ( Cecchini, G; Karliner, JS; Li, L; Simonis, U; Teerlink, JR; Zhou, HZ; Zhu, BQ, 2006) |
| "Treatment with growth hormone alone or in combination with metoprolol preserved left ventricular function after MI." | 1.31 | Growth hormone alone or combined with metoprolol preserves cardiac function after myocardial infarction in rats. ( Bengtsson, BA; Bergh, CH; Bollano, E; Caidahl, K; Isgaard, J; Kjellström, C; Kujacic, V; Omerovic, E; Waagstein, F, 2001) |
| "The treatment with metoprolol was given by subcutaneously implanted minipumps and was initiated at 3 days postinfarct and during the period of 4 weeks." | 1.31 | Selective beta(1)-blockade improves cardiac bioenergetics and function and decreases neuroendocrine activation in rats during early postinfarct remodeling. ( Bollano, E; Hjalmarson , A; Kujacic, V; Madhu, B; Mobini, R; Omerovic, E; Soussi, B; Waagstein, F, 2001) |
| " Dose-response curves of resistance arteries to ET-1 were significantly blunted in untreated hypertensive rats (maximum active tension = 2." | 1.29 | Effect of antihypertensive treatment on response to endothelin of resistance arteries of hypertensive rats. ( Deng, LY; Schiffrin, EL, 1993) |
| "Metoprolol did not cause any significant changes compared with the control group." | 1.28 | Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice. ( Kawai, C; Matsumori, A; Okada, I; Tominaga, M; Yamada, T, 1991) |
| "This study was designed to clarify whether chronic administration of metoprolol had any influence on cardiac beta-adrenergic receptors (BAR) in doxorubicin (DOX)-induced cardiac damage." | 1.28 | Chronic effects of metoprolol on myocardial beta-adrenergic receptors in doxorubicin-induced cardiac damage in rats. ( Fujita, N; Hiroe, M; Horie, T; Hosoda, S; Ohta, Y, 1991) |
| "Hyperthyroidism is frequently associated with myopathy." | 1.27 | The effect of beta-adrenergic blockade on the myopathic changes in experimental hyperthyroidism in rats. ( Angerås, U; Hasselgren, PO; Oldfors, A, 1986) |
| " The results indicate that metoprolol in a dosage of 150-450 mg daily is an effective and well tolerated therapy both in patients previously untreated and in patients unsatisfactorily treated with other antihypertensive agents." | 1.26 | Antihypertensive effect and tolerability of metoprolol during long-term treatment: a multicentre study. ( Rosengard, S, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (40.00) | 18.7374 |
| 1990's | 15 (30.00) | 18.2507 |
| 2000's | 12 (24.00) | 29.6817 |
| 2010's | 3 (6.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blain, A | 1 |
| Greally, E | 1 |
| Laval, S | 1 |
| Blamire, A | 1 |
| Straub, V | 1 |
| MacGowan, GA | 1 |
| Li, YC | 1 |
| Ge, LS | 1 |
| Yang, PL | 1 |
| Tang, JF | 1 |
| Lin, JF | 1 |
| Chen, P | 1 |
| Guan, XQ | 1 |
| Peters, H | 1 |
| Rückert, M | 1 |
| Gaedeke, J | 1 |
| Liefeldt, L | 1 |
| Ketteler, M | 1 |
| Sharma, AM | 1 |
| Neumayer, HH | 1 |
| Yuan, Z | 1 |
| Shioji, K | 1 |
| Kihara, Y | 1 |
| Takenaka, H | 1 |
| Onozawa, Y | 1 |
| Kishimoto, C | 1 |
| Hryniewicz, K | 1 |
| Androne, AS | 1 |
| Hudaihed, A | 1 |
| Katz, SD | 1 |
| Koch, HJ | 1 |
| Raschka, C | 1 |
| Zhu, BQ | 1 |
| Simonis, U | 1 |
| Cecchini, G | 1 |
| Zhou, HZ | 1 |
| Li, L | 1 |
| Teerlink, JR | 1 |
| Karliner, JS | 1 |
| Di Verniero, C | 1 |
| Höcht, C | 1 |
| Opezzo, JA | 1 |
| Taira, CA | 1 |
| Scholze, J | 1 |
| Grimm, E | 1 |
| Herrmann, D | 1 |
| Unger, T | 1 |
| Kintscher, U | 1 |
| Messerli, FH | 1 |
| Bell, DS | 1 |
| Fonseca, V | 1 |
| Katholi, RE | 1 |
| McGill, JB | 1 |
| Phillips, RA | 1 |
| Raskin, P | 1 |
| Wright, JT | 1 |
| Bangalore, S | 1 |
| Holdbrook, FK | 1 |
| Lukas, MA | 1 |
| Anderson, KM | 1 |
| Bakris, GL | 1 |
| Loss, Ide O | 1 |
| Fernandes, LG | 1 |
| Martins, CD | 1 |
| Cardoso, LM | 1 |
| Silva, ME | 1 |
| Dias-da-Silva, VJ | 1 |
| Moraes, MF | 1 |
| Chianca, DA | 1 |
| Holtzman, E | 1 |
| Rosenthal, T | 1 |
| Goldbourt, U | 1 |
| Segal, P | 1 |
| Govind, U | 1 |
| Munro, BF | 1 |
| Robertson, LI | 1 |
| Nievel, JG | 1 |
| Harvard, CW | 1 |
| Harri, M | 1 |
| Deng, LY | 1 |
| Schiffrin, EL | 2 |
| Landin, K | 1 |
| Tengborn, L | 1 |
| Smith, U | 1 |
| Dahlöf, B | 4 |
| Hosie, J | 3 |
| Jönsson, L | 1 |
| Borgholst, O | 1 |
| Ekblad, G | 1 |
| Engstrand, C | 1 |
| Grundestam, I | 1 |
| Lindh, A | 1 |
| Klein, G | 1 |
| Head, A | 1 |
| Kendall, MJ | 1 |
| Ferner, R | 1 |
| Eagles, C | 1 |
| Dimmitt, SB | 1 |
| Williams, PD | 1 |
| Croft, KD | 1 |
| Beilin, LJ | 1 |
| Farias-Silva, E | 1 |
| Grassi-Kassisse, DM | 1 |
| Wolf-Nunes, V | 1 |
| Spadari-Bratfisch, RC | 1 |
| Bengtsson, C | 2 |
| Intengan, HD | 1 |
| Omerovic, E | 2 |
| Bollano, E | 2 |
| Mobini, R | 1 |
| Madhu, B | 1 |
| Kujacic, V | 2 |
| Soussi, B | 1 |
| Hjalmarson , A | 1 |
| Waagstein, F | 2 |
| Bergh, CH | 1 |
| Kjellström, C | 1 |
| Caidahl, K | 1 |
| Bengtsson, BA | 1 |
| Isgaard, J | 1 |
| Rosengard, S | 1 |
| Tuomilehto, J | 1 |
| Pohjola, M | 1 |
| Kubik, M | 1 |
| Kendall, M | 1 |
| Ebbutt, A | 1 |
| John, V | 1 |
| Rasmussen, S | 1 |
| Rasmussen, K | 1 |
| Pedersen, OL | 1 |
| Tominaga, M | 1 |
| Matsumori, A | 1 |
| Okada, I | 1 |
| Yamada, T | 1 |
| Kawai, C | 1 |
| Brun, J | 1 |
| Fröberg, L | 1 |
| Kronmann, P | 1 |
| Olsson, LB | 1 |
| Skoog, P | 1 |
| Tygesen, G | 1 |
| Scherstén, B | 1 |
| Tibblin, G | 1 |
| Fujita, N | 1 |
| Hiroe, M | 1 |
| Ohta, Y | 1 |
| Horie, T | 1 |
| Hosoda, S | 1 |
| Adams, MA | 1 |
| Hirst, M | 1 |
| Foss, OP | 1 |
| Jensen, EK | 1 |
| Meyer-Sabellek, W | 1 |
| Schulte, KL | 1 |
| Distler, A | 1 |
| Gotzen, R | 1 |
| MacMahon, SW | 2 |
| Macdonald, GJ | 2 |
| Bernstein, L | 1 |
| Andrews, G | 1 |
| Blacket, RB | 1 |
| Angerås, U | 4 |
| Oldfors, A | 1 |
| Hasselgren, PO | 4 |
| Jagenburg, R | 2 |
| Lindstedt, G | 1 |
| Wilcken, DE | 1 |
| MacMahon, S | 1 |
| Macdonald, G | 1 |
| Ferrara, LA | 1 |
| Fasano, ML | 1 |
| Soro, S | 1 |
| Rubba, P | 1 |
| Iannuzzi, A | 1 |
| Vilming, S | 1 |
| Standnes, B | 1 |
| Hedman, C | 1 |
| Ravid, M | 1 |
| Lang, R | 1 |
| Jutrin, I | 1 |
25 trials available for metoprolol and Body Weight
| Article | Year |
|---|---|
Relation between pharmacodynamic and anthropometric parameters during ergometry at rest and after repeated intake of metoprolol in healthy volunteers: results of a pilot study.
Topics: Adrenergic beta-Antagonists; Adult; Anthropometry; Area Under Curve; Blood Pressure; Body Height; Bo | 2004 |
Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study.
Topics: Adult; Aged; Antihypertensive Agents; Appetite Depressants; Blood Pressure; Body Weight; Cyclobutane | 2007 |
Body weight changes with beta-blocker use: results from GEMINI.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Body Weight; C | 2007 |
A fixed combination of metoprolol and chlorthalidone in hypertension. A clinical trial in general practice.
Topics: Adult; Blood Pressure; Body Weight; Chlorthalidone; Clinical Trials as Topic; Drug Combinations; Fun | 1981 |
A double-blind crossover comparative study of the efficacy of single daily doses of conventional and slow-release metoprolol.
Topics: Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Delayed-Action Preparations; Dou | 1981 |
Metformin and metoprolol CR treatment in non-obese men.
Topics: Analysis of Variance; Anthropometry; Blood Pressure; Body Weight; Delayed-Action Preparations; Doubl | 1994 |
Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Body Weight; Delayed-Action Preparations; Doub | 1993 |
Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Body Weight; Delayed-Action Preparations; Doub | 1993 |
The long-term antihypertensive efficacy and safety of a new felodipine-metoprolol combination tablet. The Swedish/UK and German Study Groups.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Body Weight; Delayed-Action Preparations; Doub | 1993 |
Acute effects of beta blockade and exercise on mood and anxiety.
Topics: Adrenergic beta-Antagonists; Adult; Affect; Age Factors; Anxiety; Body Weight; Confusion; Depression | 1996 |
Effects of beta-blockers on the concentration and oxidizability of plasma lipids.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Body Weight; Cholesterol, HDL; C | 1998 |
A comparison between metoprolol and pindolol in the treatment of essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Body Weight; Drug Evaluation; Female; Heart Rate; Humans; Hypert | 1978 |
Metoprolol with and without chlorthalidone in hypertension.
Topics: Adult; Blood Pressure; Body Weight; Chlorthalidone; Clinical Trials as Topic; Drug Therapy, Combinat | 1979 |
Influence of metoprolol, alone and in combination with a thiazide diuretic, on blood pressure, plasma volume, extracellular volume and glomerular filtration rate in essential hypertension.
Topics: Adult; Benzothiadiazines; Blood Pressure; Body Weight; Clinical Trials as Topic; Diuretics; Drug The | 1979 |
Comparison of metoprolol as hydrochlorothiazide and antihypertensive agents.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Body Weight; Clinical Trials as Topic; Female; Heart | 1976 |
Optimal felodipine dose when combined with metoprolol in arterial hypertension: a Swedish multicenter study within primary health care. Swedish General Practitioner Felodipine Study Group.
Topics: Adult; Aged; Blood Pressure; Body Weight; Delayed-Action Preparations; Double-Blind Method; Drug The | 1990 |
Antihypertensive efficacy and tolerability of a fixed combination of metoprolol and felodipine in comparison with the individual substances in monotherapy. The Swedish/United Kingdom Study Group.
Topics: Adult; Aged; Blood Pressure; Body Weight; Double-Blind Method; Drug Therapy, Combination; Electrocar | 1990 |
The effect of captopril and metoprolol as monotherapy or combined with bendroflumethiazide on blood lipids.
Topics: Adult; Aged; Bendroflumethiazide; Body Weight; Captopril; Cholesterol; Cholesterol, HDL; Drug Therap | 1990 |
Circadian antihypertensive profile of carvedilol (BM 14190).
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Body Weight; Carbazoles; Carvedilol; Circadian R | 1987 |
Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients.
Topics: Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Diet, Reducing; Double-Blind Method; F | 1985 |
The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients.
Topics: Adult; Blood Pressure; Body Weight; Cardiac Volume; Cardiomegaly; Clinical Trials as Topic; Diet, Re | 1986 |
Treatment of high blood pressure in overweight patients.
Topics: Adult; Blood Pressure; Body Weight; Cardiac Volume; Cardiomegaly; Clinical Trials as Topic; Diet, Re | 1987 |
Cardiovascular effects of ketanserin, a new antiserotonergic agent in the treatment of arterial hypertension.
Topics: Adult; Blood Pressure; Body Weight; Exercise Test; Heart Rate; Hemodynamics; Humans; Hypertension; K | 1985 |
Metoprolol and pizotifen in the prophylactic treatment of classical and common migraine. A double-blind investigation.
Topics: Adolescent; Adult; Analgesics; Body Weight; Double-Blind Method; Ergotamine; Female; Humans; Male; M | 1985 |
The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
Topics: Adult; Aged; Analysis of Variance; Atenolol; Blood Pressure; Body Weight; Delayed-Action Preparation | 1985 |
25 other studies available for metoprolol and Body Weight
| Article | Year |
|---|---|
Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Calcium; Cardiomyopathies; Ion Transport; Male; M | 2013 |
Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction.
Topics: Adrenergic Antagonists; Aldehydes; Animals; Body Weight; Carbazoles; Carvedilol; Electrocardiography | 2010 |
My mother was put on the betablocker metoprolol (Toprol) for high blood pressure. Now she thinks her diabetes is out of control because of it. Can this be possible?
Topics: Adrenergic beta-Antagonists; Aged; Blood Glucose; Blood Pressure; Body Weight; Female; Humans; Hyper | 2011 |
Angiotensin-converting enzyme inhibition but not beta-adrenergic blockade limits transforming growth factor-beta overexpression in acute normotensive anti-thy1 glomerulonephritis.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzopyrans; Biomark | 2003 |
Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Antioxidants; Autoimm | 2004 |
Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Biomarkers; Blood Pressure; Body Weight; Cachexia; Carbazoles; Carvedil | 2003 |
Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury.
Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Body Weight; Cardiotonic Agents; Creatine Kinase | 2006 |
Changes in the in vitro pharmacodynamic properties of metoprolol in atria isolated from spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Dose-Response Relationship, Drug; Heart; Heart At | 2007 |
Baroreflex dysfunction in rats submitted to protein restriction.
Topics: Animals; Arteries; Atropine Derivatives; Baroreflex; Body Weight; Cardiovascular Diseases; Gene Expr | 2007 |
Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status.
Topics: Body Weight; Chlorthalidone; Cholesterol; Coronary Disease; Female; Heart Rate; Humans; Hypertension | 1984 |
Beta blockade and physical training in rats.
Topics: Animals; Blood Pressure; Body Temperature Regulation; Body Weight; Heart Rate; Metoprolol; Physical | 1982 |
Effect of antihypertensive treatment on response to endothelin of resistance arteries of hypertensive rats.
Topics: Animals; Antihypertensive Agents; Arginine Vasopressin; Blood Pressure; Body Weight; Cilazapril; Dos | 1993 |
Stress-induced alteration in the lipolytic response to beta-adrenoceptor agonists in rat white adipocytes.
Topics: Adipose Tissue; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Body Weig | 1999 |
One doctor's 25-year experience of beta-blocker treatment to the same group of hypertensive women.
Topics: Adrenergic beta-Antagonists; Adult; Alprenolol; Antihypertensive Agents; Body Weight; Continuity of | 1999 |
Disparate effects of carvedilol versus metoprolol treatment of stroke-prone spontaneously hypertensive rats on endothelial function of resistance arteries.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Carbazoles; Carvedilol; Endothelium, | 2000 |
Selective beta(1)-blockade improves cardiac bioenergetics and function and decreases neuroendocrine activation in rats during early postinfarct remodeling.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Catecholamines; Echocardiography; Energy Metaboli | 2001 |
Growth hormone alone or combined with metoprolol preserves cardiac function after myocardial infarction in rats.
Topics: Adrenergic beta-Antagonists; Aneurysm; Animals; Body Weight; Drug Therapy, Combination; Echocardiogr | 2001 |
Antihypertensive effect and tolerability of metoprolol during long-term treatment: a multicentre study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Blood P | 1977 |
Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Cardiomyopathy, Dilated; Carteolol; Drug Evaluati | 1991 |
Chronic effects of metoprolol on myocardial beta-adrenergic receptors in doxorubicin-induced cardiac damage in rats.
Topics: Animals; Body Weight; Doxorubicin; Heart Diseases; Hemodynamics; In Vitro Techniques; Iodocyanopindo | 1991 |
Metoprolol suppresses the development of ethanol-induced cardiac hypertrophy in the rat.
Topics: Adrenal Glands; Alcoholic Intoxication; Animals; Body Weight; Cardiomegaly; Catecholamines; Epinephr | 1990 |
The effect of beta-adrenergic blockade on the myopathic changes in experimental hyperthyroidism in rats.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Hyperthyroidism; Male; Metoprolol; Microscopy, El | 1986 |
Effects of beta-blocking agents on urinary excretion of 3-methylhistidine during experimental hyperthyroidism in rats.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Histidine; Hyperthyroidism; Male; Methylhistidine | 1987 |
Protein degradation in skeletal muscle during experimental hyperthyroidism in rats and the effect of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Eating; Hyperthyroidism; Male; Metoprolol; Muscle | 1987 |
Effects of thyroid hormone and beta-blocking agents on plasma amino acids in rats.
Topics: Amino Acids; Animals; Body Weight; Hyperthyroidism; Male; Metoprolol; Propranolol; Rats; Rats, Inbre | 1986 |